Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INO | AZN | AMGN | GILD | BMY |
| Company | Inovio Pharma | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.1500 | 181.48 | 321.91 | 132.84 | 57.00 |
| High | 1.1800 | 181.98 | 325.44 | 133.65 | 57.48 |
| Low | 1.1387 | 180.00 | 320.52 | 131.89 | 56.76 |
| Latest | 1.1550 | 181.26 | 326.20 | 132.35 | 57.02 |
| Change | +0.0150 | -2.20 | +2.35 | -0.34 | -0.36 |
| % Change | +1.32% | -1.20% | +0.73% | -0.26% | -0.63% |
| Volume | 649,757 | 1,683,463 | 1,273,089 | 2,040,366 | 5,103,136 |
| 20-Day Average Volume | 1,959,382 | 1,976,310 | 2,522,291 | 5,265,429 | 9,714,761 |
| Previous Close | 1.1400 | 183.46 | 323.85 | 132.69 | 57.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1317 | 194.81 | 344.36 | 134.91 | 58.61 |
| 20-Day Raw Stochastic | 62.50% | 5.42% | 12.15% | 35.39% | 5.35% |
| 20-Day Relative Strength | 40.14 | 36.81 | 36.79 | 44.01 | 44.82 |
| Weighted Alpha | -21.98 | +26.11 | +15.61 | +29.61 | +22.76 |
| Today's Opinion | 88% Sell | 8% Buy | 8% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 88% Sell | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.43% since 04/28/26 | -2.79% since 04/28/26 | -4.22% since 04/28/26 | +2.94% since 04/28/26 | -2.21% since 04/28/26 |
| Low | 1.1000 on 05/04/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.96 on 04/30/26 | 56.76 on 05/05/26 |
| High | 1.1800 on 05/05/26 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 133.65 on 05/05/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | +2.21% since 04/02/26 | -10.82% since 04/02/26 | -6.52% since 04/02/26 | -4.76% since 04/02/26 | -4.40% since 04/02/26 |
| Low | 1.0300 on 04/10/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 56.76 on 05/05/26 |
| High | 1.2300 on 04/27/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -25.96% since 02/05/26 | -3.03% since 02/05/26 | -11.57% since 02/05/26 | -10.92% since 02/05/26 | -4.28% since 02/05/26 |
| Low | 1.0300 on 04/10/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 56.45 on 03/24/26 |
| High | 2.0300 on 02/24/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -49.56% since 11/05/25 | +11.82% since 11/05/25 | +1.69% since 11/05/25 | +8.55% since 11/05/25 | +22.61% since 11/05/25 |
| Low | 1.0300 on 04/10/26 | 166.74 on 11/06/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 2.7200 on 12/17/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 79,159 | 284,529,568 | 174,776,976 | 164,697,760 | 117,154,760 |
| Shares Outstanding, K | 69,438 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 70,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -84,950,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 3,760,000 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.43 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.31 on 03/12/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/12/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.95 | 14.92 | 16.15 | 9.82 |